These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6693065

  • 1. Immunosuppressive serum factors in viral hepatitis. III. Prognostic relevance of rosette inhibitory factor and serum inhibition factor in acute and chronic hepatitis.
    Grauer W, Brattig NW, Schomerus H, Frösner G, Berg PA.
    Hepatology; 1984; 4(1):15-9. PubMed ID: 6693065
    [Abstract] [Full Text] [Related]

  • 2. Serum inhibitory factors (SIF) are of prognostic value in acute viral hepatitis.
    Wiedmann KH, Brattig NW, Diao GD, Schomerus H, Dölle W, Berg PA.
    Lancet; 1985 Feb 09; 1(8424):309-12. PubMed ID: 2857365
    [Abstract] [Full Text] [Related]

  • 3. [Serum inhibition factor in acute viral hepatitis].
    Berg PA, Brattig N.
    Leber Magen Darm; 1984 Nov 09; 14(6):261-9. PubMed ID: 6334798
    [Abstract] [Full Text] [Related]

  • 4. Prognostic relevance of serum inhibitory factors (SIF) in protracted and persistent hepatitis B.
    Brattig NW, Ortmans H, Wildhirt W, Klinge O, Berg PA.
    J Hepatol; 1987 Apr 09; 4(2):218-23. PubMed ID: 3584930
    [Abstract] [Full Text] [Related]

  • 5. Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis.
    Chisari FV, Routenberg JA, Fiala M, Edgington TS.
    J Clin Invest; 1977 Jan 09; 59(1):134-42. PubMed ID: 187620
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of serum rosette inhibitory factors in chronic liver disease.
    Zauli D, Bianchi FB, Fusconi M, Crespi C, Pisi E.
    Clin Exp Immunol; 1983 Jul 09; 53(1):145-50. PubMed ID: 6603304
    [Abstract] [Full Text] [Related]

  • 7. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
    Kakumu S, Arakawa Y, Goji H, Kashio T, Yata K.
    Gastroenterology; 1979 Apr 09; 76(4):665-72. PubMed ID: 105959
    [Abstract] [Full Text] [Related]

  • 8. [Early prognostic significance of hepatitis B surface antigen specific circulating immune complexes in acute type B viral hepatitis].
    Markus R.
    Z Gesamte Inn Med; 1990 Oct 15; 45(20):623-5. PubMed ID: 2099582
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hepatitis B surface antigen during the protracted course of viral hepatitis and chronic liver diseases].
    Belozerov ES, Sagandykov BB, Shabalin VV, Arkhipov GS.
    Klin Med (Mosk); 1979 Jun 15; 57(6):80-4. PubMed ID: 459389
    [No Abstract] [Full Text] [Related]

  • 11. Serum inhibitory factors (SIF) in patients with acute and chronic hepatitis and their clinical significance.
    Brattig N, Berg PA.
    Clin Exp Immunol; 1976 Jul 15; 25(1):40-9. PubMed ID: 991451
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the circulating immune complexes in acute and chronic liver diseases.
    Schena FP, Pastore G, Pastore A, Angarano G, Meliconi L, Schiraldi O, Bonomo L.
    J Clin Lab Immunol; 1983 Apr 15; 10(4):179-83. PubMed ID: 6864764
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Identification of hepatitis B antigens in hepatic tissue in various forms of acute hepatitis].
    Sarno EN, Vieira LM, Alvariz FG.
    Arq Gastroenterol; 1984 Apr 15; 21(2):68-74. PubMed ID: 6393924
    [Abstract] [Full Text] [Related]

  • 15. Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein.
    Chisari FV, Edgington TS.
    J Exp Med; 1975 Nov 01; 142(5):1092-1107. PubMed ID: 172585
    [Abstract] [Full Text] [Related]

  • 16. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R, Baraldini M, Stefanini GF, Facchini A, Miglio F, Bortolotti F, Alberti A, Realdi G, Amoroso P.
    Clin Exp Immunol; 1981 Nov 01; 46(2):382-90. PubMed ID: 6802539
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive serum factors in viral hepatitis. II. Further characterization of serum inhibition factor as an albumin-associated molecule.
    Brattig NW, Schrempf-Decker GE, Bröckl CW, Berg PA.
    Hepatology; 1983 Nov 01; 3(5):647-55. PubMed ID: 6618431
    [Abstract] [Full Text] [Related]

  • 18. Immune response to rabbit liver-specific lipoprotein in acute viral hepatitis.
    Ortona L, Laghi V, Cauda R, Nervo P.
    Clin Exp Immunol; 1980 Dec 01; 42(3):436-40. PubMed ID: 7214740
    [Abstract] [Full Text] [Related]

  • 19. Antibodies to polymerized human serum albumin in acute and chronic liver disease.
    Lee WM, McLeod L, Martin K, Emerson DL, Galbraith RM.
    Hepatology; 1987 Dec 01; 7(5):906-12. PubMed ID: 2820857
    [Abstract] [Full Text] [Related]

  • 20. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
    Pár A, Barna K, Bajtai G, Hollós I, Ambrus M, Kovács M, Jávor T.
    Acta Med Acad Sci Hung; 1980 Dec 01; 37(3):269-81. PubMed ID: 7457030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.